Literature DB >> 12138106

The direct binding of the catalytic subunit of protein phosphatase 1 to the PKR protein kinase is necessary but not sufficient for inactivation and disruption of enzyme dimer formation.

Seng-Lai Tan1, Semih U Tareen, Mark W Melville, Collin M Blakely, Michael G Katze.   

Abstract

The PKR protein kinase is among the best-studied effectors of the host interferon (IFN)-induced antiviral and antiproliferative response system. In response to stress signals, including virus infection, the normally latent PKR becomes activated through autophosphorylation and dimerization and phosphorylates the eIF2alpha translation initiation factor subunit, leading to an inhibition of mRNA translation initiation. While numerous virally encoded or modulated proteins that bind and inhibit PKR during virus infection have been studied, little is known about the cellular proteins that counteract PKR activity in uninfected cells. Overexpression of PKR in yeast also leads to an inhibition of eIF2alpha-dependent protein synthesis, resulting in severe growth suppression. Screening of a human cDNA library for clones capable of counteracting the PKR-mediated growth defect in yeast led to the identification of the catalytic subunit (PP1(C)) of protein phosphatase 1alpha. PP1(C) reduced double-stranded RNA-mediated auto-activation of PKR and inhibited PKR transphosphorylation activities. A specific and direct interaction between PP1(C) and PKR was detected, with PP1(C) binding to the N-terminal regulatory region regardless of the double-stranded RNA-binding activity of PKR. Importantly, a consensus motif shared by many PP1(C)-interacting proteins was necessary for PKR binding to PP1(C). The PKR-interactive site was mapped to a C-terminal non-catalytic region that is conserved in the PP1(C)2 isoform. Indeed, co-expression of PP1(C) or PP1(C)2 inhibited PKR dimer formation in Escherichia coli. Interestingly, co-expression of a PP1(C) mutant lacking the catalytic domain, despite retaining its ability to bind PKR, did not prevent PKR dimerization. Our findings suggest that PP1(C) modulates PKR activity via protein dephosphorylation and subsequent disruption of PKR dimers.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12138106     DOI: 10.1074/jbc.M205109200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  14 in total

1.  West Nile virus infection does not induce PKR activation in rodent cells.

Authors:  H Elbahesh; S V Scherbik; M A Brinton
Journal:  Virology       Date:  2011-10-07       Impact factor: 3.616

2.  Okadaic acid induces tyrosine phosphorylation of IkappaBalpha that mediated by PKR pathway in human osteoblastic MG63 cells.

Authors:  Hiroyuki Morimoto; Akiko Ozaki; Hirohiko Okamura; Kaya Yoshida; Seiichiro Kitamura; Tatsuji Haneji
Journal:  Mol Cell Biochem       Date:  2005-08       Impact factor: 3.396

3.  Andes virus nucleocapsid protein interrupts protein kinase R dimerization to counteract host interference in viral protein synthesis.

Authors:  Zekun Wang; Mohammad A Mir
Journal:  J Virol       Date:  2014-11-19       Impact factor: 5.103

4.  Respiratory syncytial virus limits alpha subunit of eukaryotic translation initiation factor 2 (eIF2alpha) phosphorylation to maintain translation and viral replication.

Authors:  Dayna J Groskreutz; Ellen C Babor; Martha M Monick; Steven M Varga; Gary W Hunninghake
Journal:  J Biol Chem       Date:  2010-06-02       Impact factor: 5.157

5.  Growth arrest and DNA damage-inducible protein GADD34 targets protein phosphatase 1 alpha to the endoplasmic reticulum and promotes dephosphorylation of the alpha subunit of eukaryotic translation initiation factor 2.

Authors:  Matthew H Brush; Douglas C Weiser; Shirish Shenolikar
Journal:  Mol Cell Biol       Date:  2003-02       Impact factor: 4.272

6.  Role of the dsRNA-dependent protein kinase (PKR) in the attenuation of protein loss from muscle by insulin and insulin-like growth factor-I (IGF-I).

Authors:  H L Eley; S T Russell; M J Tisdale
Journal:  Mol Cell Biochem       Date:  2008-03-23       Impact factor: 3.396

7.  Control of alpha subunit of eukaryotic translation initiation factor 2 (eIF2 alpha) phosphorylation by the human papillomavirus type 18 E6 oncoprotein: implications for eIF2 alpha-dependent gene expression and cell death.

Authors:  Shirin Kazemi; Stavroula Papadopoulou; Suiyang Li; Qiaozhu Su; Shuo Wang; Akihiko Yoshimura; Greg Matlashewski; Thomas E Dever; Antonis E Koromilas
Journal:  Mol Cell Biol       Date:  2004-04       Impact factor: 4.272

8.  Effect of branched-chain amino acids on muscle atrophy in cancer cachexia.

Authors:  Helen L Eley; Steven T Russell; Michael J Tisdale
Journal:  Biochem J       Date:  2007-10-01       Impact factor: 3.857

9.  Cellular serine/threonine phosphatase activity during human cytomegalovirus infection.

Authors:  Morgan Hakki; Adam P Geballe
Journal:  Virology       Date:  2008-08-30       Impact factor: 3.616

10.  Increased susceptibility of breast cancer cells to stress mediated inhibition of protein synthesis.

Authors:  Shehla Pervin; An H Tran; Shaghayegh Zekavati; Jon M Fukuto; Rajan Singh; Gautam Chaudhuri
Journal:  Cancer Res       Date:  2008-06-15       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.